Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Isofol Medical AB (publ)
AB
Active
Org 5567598064
Arvid Wallgrens Backe 20, 413 46
Göteborg
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2008
4 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Isofol Medical AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
11M
21M
32M
43M
37M
2020
22M
2021
13M
2022
1M
2023
0M
2024
EBITDA
SEK millions
0M
-12M
-24M
-36M
-48M
-186M
2020
-205M
2021
-167M
2022
-42M
2023
-47M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
37 119
22 407
12 797
721
0
Staff expenses
—
—
—
—
—
EBITDA
−186 438
−204 506
−167 476
−41 646
−47 206
Depreciation & amort.
−197
−77
−67
−37
−3
EBIT
−186 635
−204 583
−167 543
−41 683
−47 209
Net financials
−4 712
4 304
7 750
4 602
3 721
Profit before tax
−189 282
−200 280
−159 793
−37 071
−43 488
Tax
−0
−0
−0
−0
−0
Net profit
−189 282
−200 280
−159 793
−37 071
−43 488
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
145 450
400 004
209 890
140 597
98 417
Equity
66 660
318 297
158 504
121 433
77 945
Long-term debt
0
0
845
0
648
Short-term debt
78 790
81 707
50 541
18 253
19 824
Total debt
78 790
81 707
51 386
18 253
20 472
Financial ratios
5-year trend
EBITDA margin
-4720600000.0%
This company
15.8%
Market median
-29877215290% vs market
2020
2024
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
2020
2024
Return on equity
-55.8%
This company
18.4%
Market median
-403% vs market
2020
2024
Net profit margin
-4348800000.0%
This company
8.1%
Market median
-53688888989% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Isofol Medical AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
